Peter J Engel MD

Cardiology•Cincinnati, OH

Adult Congenital Heart Disease

Physician

Join to View Full Profile

2123 Auburn AveSte 137Cincinnati, OH 45219
Phone+1 513-206-1180
Fax+1 513-206-1183

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Cardiovascular Disease, 1975 - 1976
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1971 - 1975
New York University School of MedicineClass of 1971

Certifications & Licensure

OH State Medical License 1973 - 2027
KY State Medical License 1978 - 2026
IN State Medical License 1980 - 2023
CA State Medical License 2002 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
COMPLETED
PHASE4
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension Start of enrollment: 2009 Dec 01
COMPLETED
PHASE3
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) Start of enrollment: 2011 Nov 01
Unknown status
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE Start of enrollment: 2017 Feb 03
Completed
Phase 2, Phase 3
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

9 citations
Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study.
Marloes P Huitema, Marco C Post, Jan C Grutters, Athol U Wells, Vasilis Kouranos
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2022-01-01
27 citations
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
Robert P. Baughman, Oksana A. Shlobin, Rohit Gupta, Peter J. Engel, Jeffrey I. Stewart
Chest. 2021-08-04
276 citations
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron B. Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter A. Engel
The New England Journal of Medicine. 2021-01-28